Schedule 13D ownership disclosure

KINIKSA PHARMACEUTICALS LTD

Security class unavailable · CUSIP: G5269C101

Event date: 2018-05-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
20.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-031986
Form type
SC 13D
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
May 31, 2018
Reporting period
May 23, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub